产品名称
IHC Select Streptavidin-HRP, prediluted, 50 mL IHC Select Streptavidin-HRP, prediluted for IHC(P).
form
liquid
packaging
pkg of 50 mL
manufacturer/tradename
Chemicon®
IHC Select
technique(s)
immunohistochemistry: suitable (paraffin)
detection method
colorimetric
shipped in
wet ice
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Application
Prediluted for use in Immunohistochemical staining procedures. For example:
Blocking Reagent
Primary Antibody or Negative Control Reagent
Biotinylated Secondary Antibody
Streptavidin-HRP Conjugate
Chromogen
Counterstain
For best results use this conjugate in conjunction with other IHC Select detection reagents. A complete list of reagents is available at www.chemicon.com.
Blocking Reagent
Primary Antibody or Negative Control Reagent
Biotinylated Secondary Antibody
Streptavidin-HRP Conjugate
Chromogen
Counterstain
For best results use this conjugate in conjunction with other IHC Select detection reagents. A complete list of reagents is available at www.chemicon.com.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Physical form
Dropper vial containing Streptavidin conjugated to Horseradish Peroxidase in a ready-to-use format
Preparation Note
When stored at 2-8°C, this reagent is stable up to the expiration date printed on the label. Do not freeze or expose to elevated temperatures.
signalword
Warning
hcodes
Hazard Classifications
Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1
存储类别
12 - Non Combustible Liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Ilianna Zoi et al.
Breast cancer research : BCR, 21(1), 132-132 (2019-12-05)
ERBB-2 is overexpressed in about 20% of breast cancers (BCs), indicating poor prognosis. The receptor activator of nuclear factor-κB (RANK) pathway is implicated in ERBB-2 (+) BC. The purpose of this study was to elucidate the underlying molecular mechanism of
Erika Terzuoli et al.
Cancers, 11(12) (2019-12-11)
Melanoma and non-small-cell lung carcinoma (NSCLC) cell lines are characterized by an intrinsic population of cancer stem-like cells (CSC), and high expression of detoxifying isozymes, the aldehyde dehydrogenases (ALDHs), regulating the redox state. In this study, using melanoma and NSCLC
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持